ODDB.org: Open Drug Database

Helvepharm AG - M-retard Zentiva 30 mg, Retardtabletten

Swissmedic Registration	53644	Sequence	02
Product name	M-retard Zentiva 30 mg	Description	Retardtabletten
ATC-Classification	N02AA01	ATC-Description	Morphine
Introduction of Sequence	24.03.2000

Composition

morphini hydrochloridum trihydricum 30 mg corresp. morphinum 22.8 mg, lactosum monohydricum 24.74 mg, polyacrylatis dispersio 30 per centum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, ammonio methacrylatis copolymerum B, hypromellosum, magnesii stearas, Überzug: macrogolum 6000, talcum, hypromellosum, polyacrylatis dispersio 30 per centum, E 104, E 132, E 171 pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Morphini Hydrochloridum Trihydricum	30 mg correspond Morphine 22.8 mg

BAG: Active Agent	Dose
Morphini Hydrochloridum Trihydricum	30 mg

Inactive agents	Dose	additional_information
Acidi Methacrylici
Ammonio Methacrylatis Copolymerum B
E 104		color.
E 132		color.
E 171		color.
Ethylis Acrylatis Polymerisatum
Hypromellosum
Lactose Monohydrate	24.74 mg
Macrogol	6000	Überzug
Magnesii Stearas
Per Centum
Polyacrylatis Dispersio	30
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	30	13.46	31.05	A+	SL	Yes
004	60	28.53	47.45	A+	SL	Yes

2025	©ywesee GmbH